recombinant viral vector vaccine (Sumagen)

N/A

Report date: 2025/03/19 11:44:02

Base Information

Drug Namerecombinant viral vector vaccine (Sumagen)

Drug Alias NameHCV vaccine (Sumagen)HCV vaccine (University of Western Ontario)

ClassificationVaccines > Application > Prophylactic vaccineVaccines > Application > Therapeutic vaccineVaccines > Development/production technology > Recombinant vector vaccine

Mechanisms of ActionImmunomodulators

TargetsNot applicable

Therapy Area/IndicationsHepatitis C

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesUniversity Of Western Ontario

China Registration ClassN/A

Develop Information

Active CompaniesSumagen

Inactive CompaniesUniversity Of Western Ontario

Active IndicationsHepatitis C

Inactive IndicationsN/A

Other Information

ATC CodeN/A